TFS Capital’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

TFS Capital’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,625	Closed	-$706K	–	1271
2016 Q1	$706K	Buy	+7,625	New	+$762K	0.1%	354
2015 Q1	–	Sell	-1,075	Closed	-$854K	–	1205
2014 Q4	$854K	Sell	1,075 -5,579	-84%	-$3M	0.08%	406
2014 Q3	$2.65M	Buy	6,654 +2,856	+75%	+$765K	0.23%	123
2014 Q2	$1.02M	Buy	3,798 +1,765	+87%	+$379K	0.08%	394
2014 Q1	$443K	Sell	2,033 -941	-32%	-$262K	0.03%	793
2013 Q4	$804K	Buy	2,974 +2,047	+221%	+$488K	0.04%	644
2013 Q3	$211K	Buy	+927	New	+$162K	0.01%	1238

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TFS Capital's TTPH Position: Q2 2016 in Review

TFS Capital sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 7,625 shares — an estimated $706K sold.

TFS Capital first reported a position in TTPH in Q3 2013 and held it in 7 quarters. The position peaked at $2.65M in Q3 2014. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

TFS Capital reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
TFS Capital sold 7,625 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $706K.
TFS Capital first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2013 and held it in 7 quarters.
TFS Capital's Tetraphase Pharmaceuticals, Inc. position peaked at $2.65M in Q3 2014.
91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on TFS Capital's 13F filing for Q2 2016, filed 11 Aug 2016.